Coupled with observed high level of transcripts in the arachidonic pathway, it is tempting to suggest that elevated PLBD1 levels contributes to MM progression and relapse by increasing arachidonic acids levels. The gene discussed is PLBD1; the disease is Miyoshi myopathy.